← Open Payments lookup

NPI 1043227713: Open Payments

NPI 1043227713. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$111 in 6 payments from 4 companies in 2025. Trend: 2023 $120 · 2024 $86 · 2025 $111

Food & beverage: $111
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.2$31
Janssen Pharmaceuticals, Inc2$31
Axsome Therapeutics, Inc.1$26
Alkermes, Inc.1$23

Products named: COBENFY, INVEGA SUSTENNA, Auvelity, ARISTADA.